Icu Medical (ICUI) Cash from Investing Activities Growth (1y) (2010 - 2026)
Powered by 
Analysis
Icu Medical (ICUI) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | -12.26% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 618.55% |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | -186.92% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | -44.16% |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | -110.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -110.74% |
| Mar 31, 2026 | 33.32% |
| Dec 31, 2025 | 30.72% |
| Sep 30, 2025 | -31.36% |
| Jun 30, 2025 | 964.18% |
| Mar 31, 2025 | 5.88% |
| Dec 31, 2024 | 13.39% |
| Sep 30, 2024 | 6.72% |
| Jun 30, 2024 | -23.21% |
| Mar 31, 2024 | -17.64% |
| Dec 31, 2023 | -27.72% |
| Sep 30, 2023 | -95.63% |
| Jun 30, 2023 | -239.10% |
| Mar 31, 2023 | 99.19% |
| Dec 31, 2022 | 27.15% |
| Sep 30, 2022 | 40.59% |
| Jun 30, 2022 | 70.80% |
| Mar 31, 2022 | -9,792.22% |
| Dec 31, 2021 | 19.47% |
| Sep 30, 2021 | 12.43% |